Traws Pharma, Inc. Common Stock (TRAW)

NASDAQ: TRAWUSD
1.64 USD
-0.01 (-0.75%)
AT CLOSE (11:59 AM EDT)
1.66
+0.02 (+1.22%)
POST MARKET (AS OF 07:50 PM EDT)
🔴Market: CLOSED
Open?$1.67
High?$1.72
Low?$1.49
Prev. Close?$1.64
Volume?86.2K
Avg. Volume?79.4K
VWAP?$1.63
Rel. Volume?1.09x
Bid / Ask
Bid?$1.56 × 100
Ask?$1.76 × 200
Spread?$0.20
Midpoint?$1.66
Valuation & Ratios
Market Cap?13.1M
Shares Out?8.0M
Float?3.7M
Float %?46.8%
P/E Ratio?N/A
P/B Ratio?2.88
EPS?-$1.25
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.22Adequate
Quick Ratio?1.22Adequate
Cash Ratio?0.81Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
92/100
P/E?
N/A
P/B?
2.88CHEAP
P/S?
4.60FAIR
P/FCF?
N/A
EV/EBITDA?
-0.4CHEAP
EV/Sales?
2.35CHEAP
Returns & Efficiency
ROE?
-219.9%WEAK
ROA?
-80.3%WEAK
Cash Flow & Enterprise
FCF?$-22052000
Enterprise Value?$6.7M
Related Companies
Loading...
News
Profile
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.
Employees
7
Market Cap
13.1M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2013-07-25
Address
12 PENNS TRAIL
NEWTOWN, PA 18940
Phone: 267-759-3680